Takeda Pharmaceutical - 48 Year Dividend Yield History | TAK

Historical dividend payout and yield for Takeda Pharmaceutical (TAK) since 1971. The current TTM dividend payout for Takeda Pharmaceutical (TAK) as of March 19, 2019 is $0.58. The current dividend yield for Takeda Pharmaceutical as of March 19, 2019 is 2.71%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $33.231B $15.988B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.810B 31.14
Grifols (GRFS) Spain $13.208B 16.01
Mannatechorporated (MTEX) United States $0.043B 0.00